NDC 0049-3003-01 - UNASYN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0049-3003
- Requested NDC
- 0049-3003-01
- Package NDCs from labels
- 0049-3003-01, 0049-3003-10
- Manufacturer
- Roerig | Pharmacia & Upjohn Company LLC
- Effective date
- 2026-07-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| UNASYN - Roerig | Pharmacia & Upjohn Company LLC | Roerig | Pharmacia & Upjohn Company LLC | 2026-07-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| AMPICILLIN SODIUM | ACTIVE INGREDIENT | JFN36L5S8K | UNASYN (AMPICILLIN SODIUM AND SULBACTAM SODIUM) INJECTION, POWDER, FOR SOLUTION [ROERIG] | 13 | |
| SULBACTAM SODIUM | ACTIVE INGREDIENT | DKQ4T82YE6 | UNASYN (AMPICILLIN SODIUM AND SULBACTAM SODIUM) INJECTION, POWDER, FOR SOLUTION [ROERIG] | 13 | |
| AMPICILLIN | ACTIVE MOIETY | 7C782967RD | UNASYN (AMPICILLIN SODIUM AND SULBACTAM SODIUM) INJECTION, POWDER, FOR SOLUTION [ROERIG] | 13 | |
| SULBACTAM | ACTIVE MOIETY | S4TF6I2330 | UNASYN (AMPICILLIN SODIUM AND SULBACTAM SODIUM) INJECTION, POWDER, FOR SOLUTION [ROERIG] | 13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ampicillin sodium | AMPICILLIN | Civica, Inc. | 2fd0f9fa-5b86-42f7-9a9f-767123638d39 | 2025-06-30 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | 67dd2930-8482-4da5-b663-b751aff18c61 | 2025-05-16 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | Avenacy, LLC | 577dd6f0-d56a-4c82-9f72-274c3a4a0f01 | 2025-04-25 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | Avenacy, LLC | 4446d4c8-056d-4bc3-8f58-21255b063398 | 2025-04-25 | Warnings, Adverse reactions | 1659592 1659598 JFN36L5S8K DKQ4T82YE6 |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | 64a04e8c-8f78-46b3-8f45-56ef225a4f74 | 2025-02-21 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Avenacy Inc. | 19546563-50b7-4160-8cbe-f8e7079cba69 | 2025-02-01 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Athenex Pharmaceutical Division, LLC. | 06b1c203-600c-4083-986a-d1d471b56e43 | 2025-01-28 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN | Medical Purchasing Solutions, LLC | 29675d9c-3248-337a-e063-6294a90a2e20 | 2024-12-16 | Warnings, Adverse reactions | JFN36L5S8K |
| ampicillin and sulbactam | AMPICILLIN AND SULBACTAM | Sagent Pharmaceuticals | 35606b43-5914-423c-9bc7-fa3957eb2563 | 2024-11-18 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | c2908a44-1da4-4885-ae5a-23f69189d91a | 2024-10-31 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | b371e1a5-1fef-4df2-8940-c4fc02b9e2f0 | 2024-10-31 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | NorthStar Rx, LLC | 5e8d35cb-e93d-42ad-a02c-0dbf04910f61 | 2024-08-13 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | NorthStar Rx, LLC | 1e5004f1-e79e-4e0b-9f3f-25f6bbc15255 | 2024-06-27 | Warnings, Adverse reactions | 1659592 1659598 JFN36L5S8K DKQ4T82YE6 |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | 5308ddfa-4a5b-4f7b-83ce-9d1b528e050d | 2024-05-09 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | 6632a5bd-45f1-422f-80b0-46e5a628969a | 2024-05-08 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Sandoz Inc | f77db491-31c4-4a7c-a114-0f3244c97090 | 2024-05-07 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | NorthStar Rx, LLC | 6772d650-9814-49e4-a4ec-0b1a97b837d1 | 2024-02-22 | Warnings, Adverse reactions | JFN36L5S8K |
| AMPICILLIN | AMPICILLIN | HF Acquisition Co LLC, DBA HealthFirst | e47a21b1-bbdb-4321-e053-2a95a90a3b4a | 2024-01-28 | Warnings, Adverse reactions | JFN36L5S8K |
| AMPICILLIN | AMPICILLIN | HF Acquisition Co LLC, DBA HealthFirst | e51db6a3-027a-6e24-e053-2a95a90a1587 | 2024-01-14 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | Medical Purchasing Solutions, LLC | 690f1986-6da9-4787-e053-2a91aa0a2644 | 2023-05-23 | Warnings, Adverse reactions | JFN36L5S8K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.